| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |